Yerkes researchers propose ambitious new strategies for AIDS vaccine research
... Center, Emory University, believe conventional vaccine strategies should not be the only avenue explored ... propose an additional new approach to the AIDS vaccine research agenda in a commentary featured in the ... an AIDS vaccine. "Developing an effective AIDS vaccine has eluded scientists because the virus is ...GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
... in our Phase 2a clinical trial for our candidate vaccine for the prevention of AIDS. And, as we previously ... This trial is being conducted by the HIV vaccine Trials Network (HVTN), funded and supported by ... GeoVax and its efforts to develop an effective vaccine for prevention of AIDS." Dr. McNally ...School Closures May Not Be Necessary When Swine Flu Strikes
... and our scientists are working hard to have a vaccine ready for consumption by mid-October," Sebelius said. According to the CDC's Frieden, "the vaccine will most likely, at least for children, require ... of kids vaccinated," he noted. When the H1N1 vaccine is available, "we hope all providers and venues ...Many Texas Docs Not Pushing HPV Vaccine for Girls
... 48.5 percent said they always recommend HPV vaccine to girls, 68.4 percent said they were likely to recommend the vaccine to boys, and 41.7 percent agreed with the ... were more than twice as likely to recommend the vaccine as those in non-academic practices. Physicians ...Is it Exam Time for Georgia's School Children Already?
... and 11 months old. The whooping cough (pertussis) vaccine is commonly given to young children, but immunity ... that children receive the H1N1 (swine flu) vaccine in addition to the seasonal flu vaccine when it becomes commercially available to the ...Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
... with public health officials in producing a vaccine against the influenza A(H1N1) 2009 virus ," said ... Pasteur. "It is essential that we pursue the vaccine licensure pathway made available to us, while at ... Pasteur's influenza A(H1N1) 2009 monovalent vaccine supplemental application specifies the evaluation ...NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
... it has manufactured a virus-like particle (VLP) vaccine candidate against the H1N1 pandemic influenza ... good-manufacturing practices (cGMP) at its new vaccine manufacturing facility in Rockville, MD. This ... to produce almost all of the world's influenza vaccine supply. In addition, Novavax has produced ...AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
... studies of its H1N1 (swine) influenza vaccine and will manufacture clinical trial material by the end of the month. This vaccine has shown good production yields as well as ... after just a single inoculation. "Our vaccine platform provides several potential advantages ...Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
... the largest efficacy trial of a cervical cancer vaccine is published today in The Lancet . The study, ... types, 16 and 18. The study also showed that the vaccine provides cross-protection against HPV types 31, ... 18. For the first time the results show that this vaccine was effective against cervical pre-cancers ...Anthrax Vaccine Immunization Program
... The Anthrax vaccine Immunization Program (AVIP), is the name of the ... and specific civilian personnel with the anthrax vaccine . It began in earnest in 1997 by the Clinton ... concerning the methods and viability of the vaccine manufactured by BioPort , a subsidiary of ...Artificial induction of immunity
... Pasteur isolated the infectious agent from anthrax . He then derived a vaccine by altering the infectious agent so as to make it harmless and then ... are known as adjuvants . Several different adjuvants have been used in vaccine preparation. Adjuvants are also used in other ways in researching the ...More than half of Texas physicians do not always recommend HPV vaccine to girls
... The quadrivalent human papillomavirus (HPV) vaccine has been mired in controversy since it was ... 48.5 percent said they always recommend the HPV vaccine to girls, 68.4 percent said they were likely to recommend the vaccine to boys and 41.7 percent agreed with mandated ...Pitt researchers find promising candidate protein for cancer prevention vaccines
... and neck cancers. The finding suggests that a vaccine against the protein might prevent malignancies in ... we can be more confident about the safety of a vaccine strategy to immunize high-risk groups against ... year, a clinical trial of a cyclin B1 treatment vaccine in lung cancer patients, and she plans to assess ...First genetically-engineered malaria vaccine to enter human trials
... the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in ... and Immunity division, said in developing the vaccine the research team had deleted two key genes in ... malaria infection. He said it was hoped the vaccine would produce similar results in humans. ...Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma
... distant metastatic melanoma were injected with a vaccine that included each patient's own immune cells ... in the laboratory. The patient-specific vaccine is designed to stimulate the patient's immune ... p=.016). Eight patients in the dendritic cell vaccine study experienced remarkable long-term, ...Vaccine blocks malaria transmission in lab experiments
... vaccine. Antibodies induced by Pfs48/45 protein vaccine effectively blocked the sexual development of the ... of a successful transmission-blocking vaccine is an essential step in efforts to control the ... and basis for testing a transmission-blocking vaccine in humans," said Nirbhay Kumar, PhD, senior ...Ethiopian government celebrates rinderpest eradication
... Family Medicine at TUSM, repurposed a rinderpest vaccine that could be transported to rural areas without refrigeration. Delivery of the previous vaccine was problematic due to heat sensitivity. FIC's ... damaged the food supply and the economy. A vaccine commonly known as the ...Novavax Reports Second Quarter 2009 Financial Results
... first quarter, Novavax continued to advance its vaccine pipeline, improved its balance sheet by raising ... season influenza virus-like-particle ("VLP") vaccine candidate. The company is planning on reporting ... to ROVI to create a comprehensive influenza vaccine solution including a facility for the Spanish ...Microbix Sales Grow 22% For Nine Months
... over our traditional markets." Influenza vaccine Business "Influenza vaccine has been in the news since the emergence of the ... Gastle. "There is a global capacity shortage of vaccine supply as ...GenVec Reports Second Quarter 2009 Financial Results
... continues to make strides in its therapeutic and vaccine programs. We look forward to sharing additional ... with Cobra BioManufacturing. vaccine Programs GenVec expanded an existing contract with the PATH Malaria vaccine Initiative (MVI) to support the development of ...PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
... recombinant protective antigen (rPA) anthrax vaccine Third generation rPA anthrax vaccine Valortim((R)) -- a fully human monoclonal ... RypVax(TM) -- a recombinant dual antigen vaccine for plague For more information ...GeoVax Labs, Inc. Provides Clinical Studies Update
... Bulletin Board: GOVX), an Atlanta-based HIV/AIDS vaccine development company, today announced updates on ... "We have two main areas of focus for our HIV/AIDS vaccine - preventative and therapeutic," stated Robert ... clinical work for the preventative version of the vaccine have allowed the company to move up to another ...ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery
... ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, has signed an agreement with ... "Scancell is developing an exciting DNA vaccine technology and we are delighted to enter into ... Technologies continues to strengthen its vaccine pipeline through licensing and strategic ...Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from GeneTex
Description:... monoclonal [YPF19] to Yersinia pestis This antibody is used to detect Yersinia pestis . Immunogen: Purified F1 antigen from Yersinia pestis vaccine strain EV76. Specificity: This antibody recognises Y.pestis F1 capsular antigen. There is no cross-reactivity with Y.pseudotuberculosis and Y. ...Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone 1.F.1 from Abcam
Description:... Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain ....Custom Epitope Peptide Microarray from LC Sciences
Description:... Microarrays designed for immunological studies, vaccine development, and biosensor development built on the flexible and powerful Paraflo microfluidic on-chip synthesis platform. These microarrays are ...Epitope Peptide Microarray - Comprehensive Service from LC Sciences
Description:... epitope analysis service utilizing high density peptide microarrays synthesized on Paraflo microfluidic chips for immunological studies, vaccine development, and biosensor development. This comprehensive service includes assistance with your sequence designs, binding assays using sample(s) ...